ArticleJournal of oncology2022

MACC1 Promotes the Progression and Is a Novel Biomarker for Predicting Immunotherapy Response in Colorectal Cancer.

Man Xiong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.